NO20066010L - 2-(1h-indolylsulfanyl)-aryl-aminderivater for anvendelse i behandlingen av affektive lidelser, smerte, adhd og stressurininkontinens - Google Patents
2-(1h-indolylsulfanyl)-aryl-aminderivater for anvendelse i behandlingen av affektive lidelser, smerte, adhd og stressurininkontinensInfo
- Publication number
- NO20066010L NO20066010L NO20066010A NO20066010A NO20066010L NO 20066010 L NO20066010 L NO 20066010L NO 20066010 A NO20066010 A NO 20066010A NO 20066010 A NO20066010 A NO 20066010A NO 20066010 L NO20066010 L NO 20066010L
- Authority
- NO
- Norway
- Prior art keywords
- indolylsulfanyl
- adhd
- pain
- treatment
- urinary incontinence
- Prior art date
Links
- -1 1H-indolylsulfanyl Chemical group 0.000 title 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 title 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 title 1
- 208000019022 Mood disease Diseases 0.000 title 1
- 208000002193 Pain Diseases 0.000 title 1
- 206010066218 Stress Urinary Incontinence Diseases 0.000 title 1
- 125000002490 anilino group Chemical class [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58855504P | 2004-07-16 | 2004-07-16 | |
| DKPA200401121 | 2004-07-16 | ||
| US69173605P | 2005-06-17 | 2005-06-17 | |
| DKPA200500893 | 2005-06-17 | ||
| PCT/DK2005/000491 WO2006007843A1 (en) | 2004-07-16 | 2005-07-13 | 2-(1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20066010L true NO20066010L (no) | 2006-12-27 |
Family
ID=39243745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20066010A NO20066010L (no) | 2004-07-16 | 2006-12-27 | 2-(1h-indolylsulfanyl)-aryl-aminderivater for anvendelse i behandlingen av affektive lidelser, smerte, adhd og stressurininkontinens |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7678800B2 (de) |
| EP (1) | EP1771415B1 (de) |
| JP (1) | JP4865710B2 (de) |
| KR (1) | KR20070036061A (de) |
| CN (1) | CN1972911A (de) |
| AR (1) | AR052308A1 (de) |
| AT (1) | ATE420071T1 (de) |
| AU (1) | AU2005263324A1 (de) |
| BR (1) | BRPI0512073A (de) |
| CA (1) | CA2570805C (de) |
| CY (1) | CY1108942T1 (de) |
| DE (1) | DE602005012272D1 (de) |
| DK (1) | DK1771415T3 (de) |
| EA (1) | EA011418B1 (de) |
| ES (1) | ES2317266T3 (de) |
| HR (1) | HRP20090112T3 (de) |
| IL (1) | IL179924A0 (de) |
| MX (1) | MXPA06015201A (de) |
| NO (1) | NO20066010L (de) |
| PL (1) | PL1771415T3 (de) |
| PT (1) | PT1771415E (de) |
| RS (1) | RS50804B (de) |
| SI (1) | SI1771415T1 (de) |
| UA (1) | UA82610C2 (de) |
| WO (1) | WO2006007843A1 (de) |
| ZA (1) | ZA200610162B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR054394A1 (es) * | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de 2- (1h-indolilsulfanil)-aril amina |
| US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| MX2008016008A (es) * | 2006-06-16 | 2009-01-16 | Lundbeck & Co As H | Formas cristalinas de 4-[2-(4-metilfenilsulfonil)-fenil] piperidina con inhibicion combinada de la recaptacion de serotonina y norepinefrina para el tratamiento del dolor neuropatico. |
| TWI432194B (zh) | 2007-03-20 | 2014-04-01 | Lundbeck & Co As H | ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途 |
| JP2011526267A (ja) * | 2008-07-03 | 2011-10-06 | バイエル ファーマ アクチエンゲゼルシャフト | 化合物および放射性医薬品の製造方法 |
| JP2016537171A (ja) * | 2013-11-14 | 2016-12-01 | カリフォルニア インスティチュート オブ テクノロジー | 調節性眼内レンズ |
| CN104725295B (zh) | 2013-12-20 | 2019-05-24 | 广东东阳光药业有限公司 | 芳杂环类衍生物及其在药物上的应用 |
| AU2015286049B2 (en) | 2014-07-08 | 2018-03-01 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
| CN105446939B (zh) * | 2015-12-04 | 2019-02-26 | 上海兆芯集成电路有限公司 | 由装置端推核心入队列的装置 |
Family Cites Families (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3803143A (en) | 1969-09-08 | 1974-04-09 | Eisai Co Ltd | 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines |
| US4018830A (en) | 1969-09-22 | 1977-04-19 | Merck & Co., Inc. | Phenylthioaralkylamines |
| US4055665A (en) | 1974-11-25 | 1977-10-25 | Merck & Co., Inc. | Treating arrythmia with phenylthioaralkylamines |
| US4056632A (en) | 1975-07-21 | 1977-11-01 | Burroughs Wellcome Co. | 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use |
| US4241071A (en) | 1977-01-27 | 1980-12-23 | American Hoechst Corporation | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes |
| US4198417A (en) | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenoxyphenylpiperidines |
| DE3640475A1 (de) | 1986-11-27 | 1988-06-09 | Hoechst Sa Lab | Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung |
| EP0396827A1 (de) | 1989-05-09 | 1990-11-14 | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu | 2-Phenylthiobenzylamin-Derivate und Säureadditionssalze davon |
| GB8912971D0 (en) | 1989-06-06 | 1989-07-26 | Wellcome Found | Halogen substituted diphenylsulfides |
| US6645969B1 (en) * | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| CA2124206C (en) | 1991-11-25 | 2001-02-27 | John Eugene Macor | Indole derivatives |
| GB9126311D0 (en) | 1991-12-11 | 1992-02-12 | Wellcome Found | Substituted diphenylsulfides |
| GB9226532D0 (en) | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
| WO1995029897A1 (en) * | 1994-04-29 | 1995-11-09 | G.D. Searle & Co. | METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS |
| WO1996022977A1 (en) | 1995-01-23 | 1996-08-01 | Suntory Limited | Ameliorant or remedy for symptoms caused by ischemic diseases and compounds useful therefor |
| ATE195125T1 (de) | 1995-11-06 | 2000-08-15 | Dsm Nv | Verfahren zur de-esterifikation |
| CZ293595A3 (cs) | 1995-11-09 | 1999-12-15 | Farmak A. S. | Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích |
| US5912256A (en) | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| KR20000035880A (ko) | 1996-08-27 | 2000-06-26 | 이곤 이 버그 | 도파민 ｄ2 효능제 및 5ｈｔ1ａ 리간드로서의 4-아미노에톡시 인돌 |
| GB9725953D0 (en) | 1997-12-08 | 1998-02-04 | Pfizer Ltd | Compounds useful in therapy |
| DE19756036A1 (de) * | 1997-12-17 | 1999-06-24 | Merck Patent Gmbh | Amid- und Harnstoffderivate |
| US6333146B1 (en) * | 1999-03-10 | 2001-12-25 | Fuji Photo Film Co., Ltd. | Methine compound and silver halide photographic material containing the same |
| EE200100514A (et) | 1999-04-02 | 2002-12-16 | Icos Corporation | LFA-1 ICAM-idega seondumise inhibiitorid ja nendekasutamine |
| EP1175388B1 (de) | 1999-04-30 | 2006-03-15 | Trustees Of The University Of Pennsylvania | Spect abbildungsreagenzien für serotonintransporter |
| WO2001010842A2 (en) | 1999-08-04 | 2001-02-15 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
| SK4732002A3 (en) | 1999-10-13 | 2002-12-03 | Pfizer Prod Inc | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| US6410736B1 (en) | 1999-11-29 | 2002-06-25 | Pfizer Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| WO2001049678A1 (en) | 1999-12-30 | 2001-07-12 | H. Lundbeck A/S | Substituted phenyl-piperazine derivatives, their preparation and use |
| DE60009154D1 (de) | 1999-12-30 | 2004-04-22 | Lundbeck & Co As H | Phenylpiperazinyl-derivate |
| CZ20022603A3 (cs) | 1999-12-30 | 2002-10-16 | H. Lundbeck A/S | 4-fenyl-1-piperazinylové deriváty |
| EP1857109B1 (de) * | 2000-02-29 | 2010-09-22 | MediQuest Therapeutics, Inc. | Melanozyten-Tyrosinasehemmer als Aufheller von topischen Hauttypen |
| AU2001258771A1 (en) * | 2000-05-19 | 2001-11-26 | Takeda Chemical Industries Ltd. | -secretase inhibitors |
| US6455738B1 (en) * | 2000-07-13 | 2002-09-24 | Rhodia Chimie | Process for the sulfonation of an aromatic compound |
| EP1302462A4 (de) * | 2000-07-17 | 2007-07-18 | Takeda Pharmaceutical | Sulfonderivate, verfahren zu ihrer herstellung und ihre verwendung |
| AU2001279955A1 (en) * | 2000-08-18 | 2002-03-04 | Sterix Limited | 2-substituted estradiol derivative for inhibiting superoxid dismutase |
| AU2001286909B2 (en) * | 2000-09-01 | 2006-02-09 | Bayer Cropscience Ag | Disubstituted benzenes as insecticides |
| US6777446B2 (en) * | 2000-09-05 | 2004-08-17 | Tularik, Inc. | FXR modulators |
| EP1193268A1 (de) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmazeutisch aktive Sulfonamidderivate mit sowohl lipophilen als auch ionisierbaren Gruppen als Inhibitoren von Protein-JunKinasen |
| EP1325046B1 (de) * | 2000-10-06 | 2007-06-27 | Biocompatibles UK Limited | Zwitterionische polymere |
| AU2002213467A1 (en) * | 2000-10-11 | 2002-04-22 | Chemocentryx, Inc. | Modulation of ccr4 function |
| SK287337B6 (sk) | 2000-11-14 | 2010-07-07 | Merck Patent Gmbh | Použitie zlúčenín, ktoré sú kombinovanými selektívnymi inhibítormi (SSRI) reabsorpcie serotonínu (5-HT) a agonistami receptora 5-HT1A na výrobu liečiva |
| AR035521A1 (es) * | 2000-12-22 | 2004-06-02 | Lundbeck & Co As H | Derivados de 3-indolina y composicion farmaceutica que los comprende |
| US6436938B1 (en) | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
| EP1363890A4 (de) | 2001-02-07 | 2009-06-10 | Ore Pharmaceuticals Inc | Melanocortin-4-rezeptor bindende verbindungen und verfahren zu deren anwendung |
| RU2294932C2 (ru) | 2001-06-07 | 2007-03-10 | Ф.Хоффманн-Ля Рош Аг | Новые производные индола со сродством к рецептору 5-ht6 |
| EP1403255A4 (de) * | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | Rho-kinase-inhibitoren |
| UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| US7064139B2 (en) * | 2001-10-29 | 2006-06-20 | Uniroyal Chemical Company, Inc. | Method for treating retroviral infections |
| AR037352A1 (es) * | 2001-11-14 | 2004-11-03 | Schering Corp | Compuestos ligandos de los receptores de los cannabinoides, una composicion farmaceutica , y el uso de dichos compuestos para la manufactura de medicamentos |
| CA2467337A1 (en) | 2001-12-21 | 2003-07-10 | H. Lundbeck A/S | Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| US8048408B2 (en) * | 2002-01-16 | 2011-11-01 | Biocompatibles Uk Limited | Polymer conjugates |
| US20050261298A1 (en) * | 2002-01-18 | 2005-11-24 | David Solow-Cordero | Methods of treating conditions associated with an Edg-7 receptor |
| AU2003211439B2 (en) * | 2002-03-04 | 2008-11-20 | Japan Science And Technology Agency | Novel phosphonamides, process for producing the same, and use thereof |
| CA2480518C (en) * | 2002-03-29 | 2016-07-19 | Massachusetts Institute Of Technology | Light emitting device including semiconductor nanocrystals |
| DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
| EP1539693B9 (de) * | 2002-06-19 | 2008-10-08 | Schering Corporation | Agonisten des cannabinoidrezeptors |
| TW200401641A (en) * | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| CN1314669C (zh) * | 2002-09-17 | 2007-05-09 | 弗·哈夫曼-拉罗切有限公司 | 2,7－取代的吲哚以及它们作为5－ht6调节剂的用途 |
| PL376022A1 (en) * | 2002-09-17 | 2005-12-12 | F.Hoffmann-La Roche Ag | 2,4-substituted indoles and their use as 5-ht6 modulators |
| EP1402888A1 (de) * | 2002-09-18 | 2004-03-31 | Jerini AG | Verwendung von substituierte carbozyclische Verbindungen als rotamase inhibitoren |
| US20040266732A1 (en) * | 2002-09-20 | 2004-12-30 | Jorge Galvez | Therapeutic agents, methods, and treatments |
| JP2006505559A (ja) * | 2002-10-18 | 2006-02-16 | エフ．ホフマン−ラ ロシュ アーゲー | ５−ｈｔ６受容体親和性を持つ４−ピペラジニルベンゼンスルホニルインドール |
| US20040137389A1 (en) * | 2002-12-19 | 2004-07-15 | Kouta Fukui | Heat-developable light-sensitive material |
| ES2401079T3 (es) * | 2002-12-20 | 2013-04-16 | Amgen Inc. | Moduladores del asma y de la inflamación alérgica |
| CN1512264B (zh) * | 2002-12-27 | 2010-05-26 | 富士胶片株式会社 | 卤化银彩色照相感光材料 |
| DE10300098A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Ag | Kupfer-Carben-Komplexe und ihre Verwendung |
| EP2267049A1 (de) * | 2003-02-05 | 2010-12-29 | Biocompatibles UK Limited | Blockcopolymere |
| TW200505902A (en) * | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
| WO2004087153A2 (en) * | 2003-03-28 | 2004-10-14 | Chiron Corporation | Use of organic compounds for immunopotentiation |
| US7244763B2 (en) * | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| EP1671962A1 (de) * | 2003-10-10 | 2006-06-21 | Ono Pharmaceutical Co., Ltd. | Neue kondensierte heterocyclische verbindung und deren verwendung |
| US7229751B2 (en) * | 2003-11-20 | 2007-06-12 | Konica Minolta Medical & Graphic, Inc. | Silver salt photothermographic dry imaging material and image forming method using the same |
| EP1694323A4 (de) * | 2003-12-19 | 2009-05-13 | Elixir Pharmaceuticals Inc | Verfahren zur behandlung einer erkrankung |
| EP1701940B1 (de) * | 2003-12-23 | 2008-05-28 | H.Lundbeck A/S | 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri |
| SE528250C2 (sv) * | 2004-02-27 | 2006-10-03 | Calignum Technologies Ab | Komposition innefattande en initiator och ett förfarande för att behandla trä med kompositionen |
| JP4569142B2 (ja) * | 2004-03-22 | 2010-10-27 | コニカミノルタホールディングス株式会社 | 表示素子 |
| JP4448730B2 (ja) * | 2004-04-20 | 2010-04-14 | 富士フイルム株式会社 | 感光性組成物、該感光性組成物に用いられる化合物及び該感光性組成物を用いたパターン形成方法 |
| WO2006006172A2 (en) | 2004-07-15 | 2006-01-19 | Ramot At Tel Aviv University Ltd. | Use of anti-amyloid agents for treating and typing pathogen infections |
| EP1867704B1 (de) | 2005-03-15 | 2010-09-15 | FUJIFILM Corporation | Oberflächenbehandlungsverfahren unter verwendung einer scheibenartigen verbindung, (schmier)zusammensetzung zur oberflächenbehandlung und oberflächenbehandelter gegenstand |
-
2005
- 2005-07-12 AR ARP050102877A patent/AR052308A1/es not_active Application Discontinuation
- 2005-07-13 AT AT05759183T patent/ATE420071T1/de active
- 2005-07-13 BR BRPI0512073-0A patent/BRPI0512073A/pt not_active IP Right Cessation
- 2005-07-13 UA UAA200612493A patent/UA82610C2/uk unknown
- 2005-07-13 JP JP2007520664A patent/JP4865710B2/ja not_active Expired - Fee Related
- 2005-07-13 PT PT05759183T patent/PT1771415E/pt unknown
- 2005-07-13 KR KR1020067025769A patent/KR20070036061A/ko not_active Withdrawn
- 2005-07-13 ES ES05759183T patent/ES2317266T3/es not_active Expired - Lifetime
- 2005-07-13 US US11/629,043 patent/US7678800B2/en not_active Expired - Fee Related
- 2005-07-13 WO PCT/DK2005/000491 patent/WO2006007843A1/en not_active Ceased
- 2005-07-13 MX MXPA06015201A patent/MXPA06015201A/es not_active Application Discontinuation
- 2005-07-13 CN CNA200580020862XA patent/CN1972911A/zh active Pending
- 2005-07-13 DK DK05759183T patent/DK1771415T3/da active
- 2005-07-13 CA CA2570805A patent/CA2570805C/en not_active Expired - Fee Related
- 2005-07-13 PL PL05759183T patent/PL1771415T3/pl unknown
- 2005-07-13 RS RSP-2009/0070A patent/RS50804B/sr unknown
- 2005-07-13 EA EA200602180A patent/EA011418B1/ru not_active IP Right Cessation
- 2005-07-13 HR HR20090112T patent/HRP20090112T3/xx unknown
- 2005-07-13 ZA ZA200610162A patent/ZA200610162B/en unknown
- 2005-07-13 DE DE602005012272T patent/DE602005012272D1/de not_active Expired - Lifetime
- 2005-07-13 EP EP05759183A patent/EP1771415B1/de not_active Expired - Lifetime
- 2005-07-13 AU AU2005263324A patent/AU2005263324A1/en not_active Abandoned
- 2005-07-13 SI SI200530606T patent/SI1771415T1/sl unknown
-
2006
- 2006-12-07 IL IL179924A patent/IL179924A0/en unknown
- 2006-12-27 NO NO20066010A patent/NO20066010L/no not_active Application Discontinuation
-
2009
- 2009-03-31 CY CY20091100373T patent/CY1108942T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2570805A1 (en) | 2006-01-26 |
| EA200602180A1 (ru) | 2007-04-27 |
| CN1972911A (zh) | 2007-05-30 |
| EA011418B1 (ru) | 2009-02-27 |
| US20080027074A1 (en) | 2008-01-31 |
| KR20070036061A (ko) | 2007-04-02 |
| JP4865710B2 (ja) | 2012-02-01 |
| UA82610C2 (uk) | 2008-04-25 |
| ES2317266T3 (es) | 2009-04-16 |
| EP1771415A1 (de) | 2007-04-11 |
| ZA200610162B (en) | 2008-06-25 |
| MXPA06015201A (es) | 2007-03-15 |
| SI1771415T1 (sl) | 2009-04-30 |
| IL179924A0 (en) | 2007-05-15 |
| WO2006007843A1 (en) | 2006-01-26 |
| AR052308A1 (es) | 2007-03-14 |
| CY1108942T1 (el) | 2014-07-02 |
| HRP20090112T3 (hr) | 2009-03-31 |
| BRPI0512073A (pt) | 2008-02-06 |
| RS50804B (sr) | 2010-08-31 |
| EP1771415B1 (de) | 2009-01-07 |
| DE602005012272D1 (de) | 2009-02-26 |
| AU2005263324A1 (en) | 2006-01-26 |
| PT1771415E (pt) | 2009-03-16 |
| DK1771415T3 (da) | 2009-02-23 |
| US7678800B2 (en) | 2010-03-16 |
| JP2008506640A (ja) | 2008-03-06 |
| ATE420071T1 (de) | 2009-01-15 |
| CA2570805C (en) | 2010-08-24 |
| PL1771415T3 (pl) | 2009-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE476418T1 (de) | Benzamidderivate und assoziierte verwendungen | |
| NO20064282L (no) | Morfolinforbindelser | |
| NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
| CY1108230T1 (el) | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri | |
| NO20064599L (no) | Substituerte morfolin- og tiomorfolinderivater | |
| NO20054848L (no) | Substituerte p-diaminobenzenderivater | |
| PE20090694A1 (es) | Compuestos moduladores de sirtuinas | |
| NO20081942L (no) | Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser | |
| NO20082136L (no) | 1,5-substituerte indol-2-yl-amidderivater | |
| NO20074275L (no) | 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister | |
| NO20082112L (no) | 3-Amino-2-arylpropylazaindoler og deres anvendelse | |
| WO2007145835A3 (en) | Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity | |
| NO20084418L (no) | Azolopyridin-3-on derivater som inhibitorer av endoteliallipase | |
| NO20083058L (no) | Cykloheksylsulfonamidderivater med H3 reseptor aktivitet | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| NO20084048L (no) | Benzimidazoler som har aktivitet ved M1 receptor og deres anvendelser i medisin | |
| CY1108942T1 (el) | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-αρυλαμινης δια χρησιν εις την θεραπειαν συναισθηματικων διαταραχων, πονου, adhd και αγχους ακρατειας ουρων | |
| NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
| NO20082214L (no) | 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer | |
| NO20062453L (no) | Tiozolidinoner, fremstilling og anvendelse derav som legemidler | |
| NO20052699L (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser. | |
| TW200639155A (en) | Thiazolidinones, their production and use as pharmaceutical agents | |
| NO20063619L (no) | Diarylmetylpiperazinderivater, fremstilling og anvendelse derav | |
| NO20054721L (no) | Substituerte anilinderivater | |
| ATE531703T1 (de) | Benzochromenderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |